This is an extraordinary commitment that we have not seen from any other provider in our review database
doi: 10.1097/00013611-199903000-00004
#Semaglutide I #Patent_cliff I #Market I #generics I #global_scale I #India I Systematix Group Read more: To view or add a comment, sign in Analysis: The loss of #Semaglutide patents is a major strategic turning point for #IndianPharma, unlocking an estimated 5,000 crore (~$600M) #GenericOpportunity across #India and regulated #EmergingMarkets like #Canada and #Brazil as exclusivity ends
You can take Wegovy if youre over 18, need help managing your weight, and do not have any conditions or take any medications that interact with semaglutide and could make it unsafe
Ill definitely be back for more
Specifically formulated to target hyperpigmentation, dark spots, sunburns, and discolourations, this advanced formula is your key to brighter skin